Methodology core
方法论核心
基本信息
- 批准号:10017672
- 负责人:
- 金额:$ 36.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-20 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
ABSTRACT
The foci of expertise in the VERITY Methodology Core align with the overall objectives of the CCCR
(“VERITY”). First, VERITY is the hub of rheumatic and MSK disease clinical research in our growing, vibrant
Research Community, and the Core has the breadth of expertise to enhance the rigor of the broad range of
studies undertaken in our Research Community. Second, one of the key VERITY objectives is to design
interventions whose efficacy should be evaluated in studies providing the highest level of evidence, including
RCTs when feasible and observational studies when randomization cannot occur. The Methodology Core will
contribute to this mission by optimizing trial design to expedite the translation of efficacious new treatments into
clinical practice. Similarly, the Core’s work on prioritization of RCTs is needed to focus resources on trials that
have the greatest opportunity to advance clinical care. Finally, the Core advances VERITY’s focus on patient-
centeredness. We have the ability to harness advancements in information technology and health-promoting
wearable devices to design and implement studies that improve patients’ engagement, self-management,
adherence, physical activity, and well-being. Care can be personalized and outcomes improved through novel
interventions that draw from genetic and environmental risk assessment and counseling, disease risk
calculators, behavioral economics, health coaching, and efforts to reduce health disparities. The key Specific
Aims of the Methodology Core are: Aim 1: To ensure the highest possible methodological rigor in the design
and implementation of studies aimed at improving outcomes in persons with rheumatic and musculoskeletal
conditions. Aim 2: To develop and advance methods to optimize design and conduct of clinical trials. Aim 3:
To incorporate intervention approaches based on behavioral theory and behavioral economic principles and to
infuse cultural perspectives and perceptions of racial and ethnic minorities into interventions.
The Methodology Core links innovative ideas from the Research Community with rigorous study designs,
innovative trials, methods development, data management and analysis, compliance with data safety and
Health Insurance Portability and Accountability Act (HIPAA) regulations, and clear reporting of findings.
抽象的
Verity方法论核心方面的专业知识的焦点与CCCR的整体目标保持一致
(“ Verity”)。首先,Verity是流变和MSK疾病临床研究的枢纽
研究界和核心具有广泛的专业知识,可以增强广泛的严格
在我们的研究社区进行的研究。第二,关键的真实目标之一是设计
在提供最高证据的研究中应评估效率的干预措施,包括
当无法进行随机化时可行和观察性研究时,RCT会发生。方法核心将
通过优化试验设计来加快将有效的新疗法转化为
临床实践。同样,核心在RCT的优先级方面的工作也需要将资源集中在试验上
有最大的机会来促进临床护理。最后,核心的促进了Verity对患者的关注 -
中心。我们有能力利用信息技术和促进健康的进步
可穿戴设备设计和实施研究,以改善患者的参与,自我管理,
坚持,体育锻炼和福祉。可以个性化的护理,并通过小说改善结果
遗传和环境风险评估和咨询,疾病风险的干预措施
计算器,行为经济学,健康指导以及减少健康差异的努力。特定于关键
方法论核心的目的是:目标1:确保设计中最高的方法论严格性
并实施旨在改善风湿性和肌肉骨骼的人的结果的研究
状况。目标2:开发和推进方法以优化临床试验的设计和进行。目标3:
根据行为理论和行为经济原则结合干预方法,并
注入文化观点以及对种族和少数民族的看法。
方法论核心将研究界的创新思想与严格的研究设计联系起来,
创新的试验,方法开发,数据管理和分析,遵守数据安全和
健康保险可移植性和问责制法(HIPAA)法规,并清楚地报告调查结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Elena Losina的其他基金
HIV and musculoskeletal frailty: implications for care, policy and research
艾滋病毒和肌肉骨骼脆弱:对护理、政策和研究的影响
- 批准号:1068611410686114
- 财政年份:2022
- 资助金额:$ 36.51万$ 36.51万
- 项目类别:
HIV and musculoskeletal frailty: implications for care, policy and research
艾滋病毒和肌肉骨骼脆弱:对护理、政策和研究的影响
- 批准号:1055273810552738
- 财政年份:2022
- 资助金额:$ 36.51万$ 36.51万
- 项目类别:
Knee Arthroplasty Activity Trial (KArAT)
膝关节置换术活动试验 (KArAT)
- 批准号:1070951010709510
- 财政年份:2022
- 资助金额:$ 36.51万$ 36.51万
- 项目类别:
Knee Arthroplasty Activity Trial (KArAT)
膝关节置换术活动试验 (KArAT)
- 批准号:1051764610517646
- 财政年份:2022
- 资助金额:$ 36.51万$ 36.51万
- 项目类别:
Knee Arthroplasty AcTivity (KArAT) Trial
膝关节置换术活动 (KArAT) 试验
- 批准号:98839579883957
- 财政年份:2020
- 资助金额:$ 36.51万$ 36.51万
- 项目类别:
Optimizing the value of pain management in knee OA patients with comorbidities
优化疼痛管理对患有合并症的膝骨关节炎患者的价值
- 批准号:1019775610197756
- 财政年份:2018
- 资助金额:$ 36.51万$ 36.51万
- 项目类别:
Optimizing the value of pain management in knee OA patients with comorbidities
优化疼痛管理对患有合并症的膝骨关节炎患者的价值
- 批准号:99751019975101
- 财政年份:2018
- 资助金额:$ 36.51万$ 36.51万
- 项目类别:
Optimizing the value of pain management in knee OA patients with comorbidities
优化疼痛管理对患有合并症的膝骨关节炎患者的价值
- 批准号:1046862510468625
- 财政年份:2018
- 资助金额:$ 36.51万$ 36.51万
- 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Preventing Firearm Suicide Deaths Among Black/African American Adults
防止黑人/非裔美国成年人因枪支自杀死亡
- 批准号:1081149810811498
- 财政年份:2023
- 资助金额:$ 36.51万$ 36.51万
- 项目类别:
Comparative Risk of Oral Complications Associated with Medications for Opioid Use Disorder: A Mixed-Methods Approach
与阿片类药物使用障碍药物相关的口腔并发症的风险比较:混合方法
- 批准号:1076504910765049
- 财政年份:2023
- 资助金额:$ 36.51万$ 36.51万
- 项目类别:
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department
智能屏幕:利用数字健康改善急诊科青少年的艾滋病毒筛查和预防
- 批准号:1071167910711679
- 财政年份:2023
- 资助金额:$ 36.51万$ 36.51万
- 项目类别: